Palonosetron and Hydroxyzine to Reduce Opioid Withdrawal

NCT00661674 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Substance-Related Disorders

Interventions

DRUG: Palonosetron
DRUG: Hydroxyzine
OTHER: Placebo

Sponsor

Stanford University